343 filings
6-K
PRTG
Portage Biotech Inc
12 Apr 24
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
5:21pm
6-K
PRTG
Portage Biotech Inc
8 Mar 24
Current report (foreign)
5:04pm
6-K
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
6-K
PRTG
Portage Biotech Inc
28 Feb 24
Company focused on adenosine platform clinical development
6:42pm
6-K
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
6-K
pwbax
18 Jan 24
Current report (foreign)
5:09pm
6-K
4ncql77jfplaiappcw5u
4 Jan 24
Current report (foreign)
8:10am
6-K
hqncjkm6ux aj613
28 Nov 23
PORT 2 and 6 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting
4:02pm
6-K
7axfyj r55ckvg
28 Nov 23
Current report (foreign)
4:01pm
6-K
0sa0 qhda
13 Nov 23
Current report (foreign)
6:10am
6-K
zhqc4
3 Oct 23
Current report (foreign)
4:05pm
6-K
l1r 3k6p2k
29 Sep 23
Portage Biotech Announces $6.0 Million Registered Direct Offering
8:01am
6-K
uc7jf622m3ocg
8 Sep 23
Current report (foreign)
4:01pm
6-K
gfqmjp
30 Aug 23
Current report (foreign)
8:00am
6-K
cved7nydpikd
29 Aug 23
Current report (foreign)
4:01pm
6-K
zlqmc
14 Aug 23
Current report (foreign)
4:52pm
6-K
qhd2fo5i 95b
31 Jul 23
Current report (foreign)
6:10pm
6-K
z2hx 6c715g
20 Jun 23
Current report (foreign)
5:53pm
6-K
18bvi8 pcu
1 May 23
Current report (foreign)
8:00am
6-K
qzkv1jbnffyb7755t
13 Mar 23
Current report (foreign)
6:16pm